Atlas Antibodies Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 81
Employees
  • Latest Deal Type
  • 2ndary - Private

Atlas Antibodies General Information

Description

Developer of novel antibodies designed to provide advanced research reagents targeting all human proteins. The company's novel antibodies are studied for basic research purposes and clinical research, enabling researchers to know and assist patients to cure of cancer and neurological brain diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Voltavägen 13A
  • 168 69 Bromma
  • Sweden
+46 08-545 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atlas Antibodies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Generating Revenue
2. Secondary Transaction - Private 01-Mar-2013 Completed Generating Revenue
1. Seed Round 22-Aug-2006 Completed Startup
To view Atlas Antibodies’s complete valuation and funding history, request access »

Atlas Antibodies Executive Team (15)

Name Title Board Seat Contact Info
John Daicic Ph.D Chief Executive Officer
Martin Skoglund Chief Financial Officer
Anna Renglin Lindh Chief Operating Officer
Maria Hjortsmark Chief Marketing Officer
Caroline Kampf Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 15 executive team members. Get the full list »

Atlas Antibodies Board Members (8)

Name Representing Role Since
Else Trautner Self Board Member 000 0000
Lennart Johansson Atlas Antibodies Board Member 000 0000
Lotta Ljungqvist Ph.D Self Board Member 000 0000
Mathias Uhlén Ph.D Atlas Antibodies Co-Founder & Board Member 000 0000
Sophia Hober Ph.D Atlas Antibodies Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Atlas Antibodies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atlas Antibodies Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 16-Feb-2021 000000000000000000 Drug Discovery 0000 000000 00.0
Alligator Bioscience 29-May-2007 Later Stage VC 00.000 Drug Discovery 0000000 000é0 00.0
To view Atlas Antibodies’s complete investments and acquisitions history, request access »

Atlas Antibodies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 29-May-2007 00000 00000 00 00.000 Completed
  • 18 buyers
To view Atlas Antibodies’s complete exits history, request access »